DSM and Evonik select Nebraska for production of breakthrough omega-3 from natural marine algae_by chemwinfo

Blair, Nebraska was chosen as it takes advantage

of Evonik’s decades of operational experience

for large-scale biotechnology operations.

The company has been operating a facility there

for the fermentative production of Biolys^® 

- the amino acid L-lysine - for almost 20 years.

As an investor and employer Evonik has built

a consistent reputation in the local community.

The new plant will be located adjacent to

Evonik’s current facility on Cargill’s site,

with established access to the raw materials needed

to produce the high value and

pure EPA+DHA omega-3 fatty acid oil.

Both companies announced in March 2017

the start of a joint venture for this purpose.

READ MORE

It will, for the first time, allow for

the production of omega-3 fatty acids for animal nutrition

without using any fish oil from wild caught fish,

a finite resource.

Initial applications will be in salmon aquaculture and pet food.

DSM’s and Evonik’s highly concentrated algal oil

will enable the animal nutrition industry to keep up with

the increasing demand for

these two essential omega-3 fatty acids

without endangering fish stocks, helping to contribute to

healthy animal nutrition as well as

to the ecological balance and biodiversity of the oceans.

Until the facility in Blair opens, DSM

and Evonik

will produce pilot-scale quantities of the algal oil

at DSM’s production facility

in Kingstree, South Carolina (United States).

Customers will be able to receive sizeable quantities

of the product for market development

while the construction

of the new manufacturing plant gets underway.